An oral antiviral, Paxlovid has proved successful at reducing the chances of hospitalization among COVID-19 sufferers, but has suffered from a slow rollout to pharmacies across the US.
How much of a game-changer could it be in fighting COVID-19?high risk of severe disease and possibly death
But the more medically complicated a person is – by which I mean the more health conditions they have and medications they take – the more likely it is that Paxlovid will . That means that one drug could alter or interfere with how another drug works, which can be dangerous. The No. 1 issue is probably going to be the hesitancy of physicians to prescribe it. I think part of that comes down to a lack of awareness, and part is the result of the complexity of making sure that you’re using it appropriately and not hurting your patient through the drug interactions.